Accelerated amyloid neurodegeneration in HIV-1-infected APP-KI Alzheimer’s disease mice

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

INTRODUCTION

A higher incidence of dementia, including Alzheimer ’s-like pathology, is observed in aged people living with HIV-1. However, mechanisms linking HIV-1 to Alzheimer’s disease (AD) pathology remain unclear, due to the lack of animal models that allow for concurrent study.

METHODS

We created a novel APP knock-in (KI) AD mouse, NOG/APP KM670,671NL /IL-34 (hNAIL) that permits study of progressive brain HIV-1 replication. The mice harbor human microglia-like cells. Four-month-old CD34+ human cell reconstituted mice infected with the HIV-1 ADA strain facilitated studies of HIV-1 replication on AD pathologies.

RESULTS

HIV-1 replication increased Aβ levels and reduced synaptic and neuronal integrity. Spatial transcriptomics demonstrated distinct Aβ and HIV-1 transcriptional patterns, whereas dual diseased combinations amplified AD pathology. Neurons showed highest transcriptional change, with genes linked to neuroinflammation, protein trafficking, and synaptic dysfunction.

DISCUSSION

The hNAIL mice enable interrogation of HIV-AD comorbidities, with a future potential for the development of novel therapeutic interventions.

Article activity feed